We are live on ! Find out more
CM

Caption Management Portfolio holdings

AUM $17.1B
1-Year Est. Return 70.99%
This Fund
S&P 500
This Quarter Est. Return
+0.98%
1 Year Est. Return
+70.99%
3 Year Est. Return
+176.06%
5 Year Est. Return
+263.89%
10 Year Est. Return
AUM
$8.92B
AUM Growth
+$174M
Cap. Flow
+$610M
Cap. Flow %
6.84%
Top 10 Hldgs %
9.99%
Holding
2,113
New
656
Increased
339
Reduced
297
Closed
567

Top Buys

Rank Stock Value
1
TCOM icon
Trip.com Group
TCOM
+$23.1M
2
Z icon
Zillow
Z
+$21.8M
3
DVN icon
Devon Energy
DVN
+$20.9M
4
ZNGA
ZYNGA INC. CL A COMMON
ZNGA
+$16.6M
5
TECK icon
Teck Resources
TECK
+$16.1M

Sector Composition

Rank Sector Weight
1 Healthcare 3.18%
2 Technology 2.63%
3 Energy 2.29%
4 Materials 2.2%
5 Consumer Discretionary 1.97%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SNAP icon
1126
Snap
SNAP
$9.74B
$801K 0.01%
+17,000
New +$957K
KEY icon
1127
PUT
KeyCorp
KEY
$24.8B
$800K 0.01%
34,600
NAT icon
1128
Nordic American Tanker
NAT
$1.33B
$792K 0.01%
+469,663
New +$1.01M
BLNK icon
1129
PUT
Blink Charging
BLNK
$80.5M
$791K 0.01%
+29,800
New +$959K
URNM icon
1130
Sprott Uranium Miners ETF
URNM
$1.89B
$791K 0.01%
+22,000
New +$944K
URNM icon
1131
PUT
Sprott Uranium Miners ETF
URNM
$1.89B
$791K 0.01%
+22,000
New +$944K
NKLA
1132
PUT
DELISTED
Nikola Corporation Common Stock
NKLA
$790K 0.01%
2,667
TRIP icon
1133
TripAdvisor
TRIP
$1.67B
$782K 0.01%
28,700
+9,898
+53% +$303K
AIOT
1134
PowerFleet Inc
AIOT
$576M
$782K 0.01%
165,052
ENTA icon
1135
CALL
Enanta Pharmaceuticals
ENTA
$387M
$778K 0.01%
+10,400
New +$816K
TVTX icon
1136
CALL
Travere Therapeutics
TVTX
$5.21B
$775K 0.01%
25,000
-125,000
-83% -$3.52M
RDFN
1137
CALL
DELISTED
Redfin
RDFN
$767K 0.01%
20,000
CRNC icon
1138
PUT
Cerence
CRNC
$424M
$766K 0.01%
+10,000
New +$882K
BCRX icon
1139
CALL
BioCryst Pharmaceuticals
BCRX
$2.29B
$764K 0.01%
55,000
-275,000
-83% -$3.64M
SEER icon
1140
PUT
Seer Inc
SEER
$122M
$763K 0.01%
33,500
+21,000
+168% +$605K
UUUU icon
1141
CALL
Energy Fuels
UUUU
$3.21B
$763K 0.01%
100,000
-150,100
-60% -$1.27M
LW icon
1142
Lamb Weston
LW
$7.31B
$761K 0.01%
+12,000
New +$692K
AVIR icon
1143
PUT
Atea Pharmaceuticals
AVIR
$376M
$760K 0.01%
+85,000
New +$1.32M
FTHM icon
1144
Fathom Holdings
FTHM
$28.9M
$757K 0.01%
+37,041
New +$863K
ASND icon
1145
Ascendis Pharma A/S
ASND
$16B
$753K 0.01%
+5,600
New +$833K
SAND
1146
DELISTED
Sandstorm Gold
SAND
$751K 0.01%
121,100
LICY
1147
PUT
DELISTED
Li-Cycle Holdings Corp.
LICY
$748K 0.01%
+9,375
New +$885K
INO icon
1148
PUT
Inovio Pharmaceuticals
INO
$68.5M
$747K 0.01%
+12,500
New +$1M
ARWR icon
1149
CALL
Arrowhead Research
ARWR
$12.6B
$743K 0.01%
11,200
-13,800
-55% -$948K
CHGG icon
1150
Chegg
CHGG
$115M
$743K 0.01%
+24,200
New +$982K

Similar funds

Caption Management's Q4 2021 Portfolio in Review

As of Q4 2021, Caption Management held 2,113 positions worth $8.92B, up 2% from $8.75B the previous quarter. Its ten largest holdings account for 10% of the portfolio.

Caption Management deployed $610M of net new capital in Q4 2021, opening 656 new positions and adding to 339 existing holdings. Its largest new stake was Zillow: 302,083 shares worth $19.3M.

By sector, the portfolio is most concentrated in Healthcare at 3.2% of assets, down from 3.5% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Charter Communications, an estimated $22.5M trimmed.

  • Caption Management's largest Q4 2021 buy was Zillow: 302,083 shares worth $19.3M.
  • Caption Management added most to Trip.com Group in Q4 2021, an estimated $23.1M increase.
  • Caption Management's biggest Q4 2021 reduction was Charter Communications, cutting an estimated $22.5M.
  • Caption Management fully exited Meta Platforms (Facebook) in Q4 2021, selling an estimated $33.2M.
  • Caption Management's ten largest holdings make up 10% of its $8.92B portfolio in Q4 2021.
  • Caption Management opened 656 new positions and closed 567 in Q4 2021.
  • Caption Management's portfolio value rose 2% quarter-over-quarter to $8.92B.

Based on Caption Management's 13F filing for Q4 2021, filed 11 Feb 2022.